# Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients

> **NCT02461758** · PHASE4 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 81 (actual)

## Conditions studied

- Inflammatory Bowel Disease (IBD)

## Interventions

- **BIOLOGICAL:** Standard dose Influenza vaccine (SDIV)
- **BIOLOGICAL:** High dose influenza vaccine (HDIV)

## Key facts

- **NCT ID:** NCT02461758
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-06
- **Final completion:** 2018-07
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2019-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02461758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02461758, "Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02461758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*